週次 |
日期 |
單元主題 |
第1週 |
2/21 |
Introduction of Hematology/Hematopoiesis
/Introduction of Hematology experiment/Check in
|
第3週 |
3/07 |
Erythropoiesis/Routine tests in hematology/
Manual CBC count, Hct, RBC indices (exp 1)
|
第4週 |
3/14 |
General aspects of erythrocytes/General aspects of anemias/Hypochromic anemias/Iron overload
|
第5週 |
3/21 |
Megaloblastic anemias and other macrocytic anemias/Leukopoeisis/Smear preparation and staining (exp 2) |
第6週 |
3/28 |
Hemolytic anemias/Reticulocyte counting (exp 3)/Dry lab: Osmotic fragility test, sugar water test, sucrose hemolysis test, acid ham test (exp 4) |
第8週 |
4/11 |
Genetic disorders of hemoglobin/Hb EP, HbA2 (exp 5)/Acid elution test (exp 6) |
第9週 |
4/18 |
Lecture期中考 (一) (2/21-3/28, 17hrs)/Automated blood cell counter/Data management in automated blood cell analyzer XE2100
|
第10週 |
4/25 |
Quality assurance in automated blood cell analyzer/Bone marrow overview/Morphological examination of leukocytes in normal peripheral blood/Examination of the normal PB smears (exp 7)
|
第11週 |
5/02 |
Morphologic and distributive leukocyte disorders/Introduction to hematopoietic neoplasms/Leukocyte morphological changes in the infectious diseases (exp 8)/Smear observation in RBC diseases (exp 9) |
第12週 |
5/09 |
Aplastic anemia and bone marrow failure/Acute myeloid leukemia/Acute lymphoid leukemia
|
第13週 |
5/16 |
Lecture期中考 (二, 4/11 - 5/9, 19hrs)/Myeloproliferative neoplasms (including CML)/Morphological observation of myeloid cells in differentiation/Smear observation (CML) (exp 10) |
第14週 |
5/23 |
Cytogenetics/Myelodysplasia/Smear observation (CML)-2 (exp 11) |
第15週 |
5/30 |
Application of cytochemical stains in clinical hematology/Demo: Morphological and cytochemical characterization of acute leukemias (exp 12)/Dry lab: Application of cytochemical stains in differential diagnosis of acute leukemias (exp 13) |
第16週 |
6/06 |
Flow cytomeric analysis in hematologic disorders/Leukocyte alkaline phosphastase (LAP) score/LAP staining and scoring (exp 14) |
第17週 |
6/13 |
Stem cell transplantation/CLL, Hodgkin and non-Hodgkin lymphoma/Multiple myeloma and related disorders |